We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.66%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$15.1B
AUM Growth
+$742M
Cap. Flow
-$196M
Cap. Flow %
-1.3%
Top 10 Hldgs %
36.33%
Holding
1,380
New
61
Increased
578
Reduced
366
Closed
37

Sector Composition

Rank Sector Weight
1 Real Estate 54.29%
2 Technology 12.23%
3 Consumer Discretionary 4.83%
4 Communication Services 4.52%
5 Healthcare 4.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVDL
1176
DELISTED
Avadel Pharmaceuticals
AVDL
$4K ﹤0.01%
245
CRNX icon
1177
Crinetics Pharmaceuticals
CRNX
$8.87B
$4K ﹤0.01%
199
DAWN
1178
DELISTED
Day One Biopharmaceuticals
DAWN
$4K ﹤0.01%
296
ETNB
1179
DELISTED
89bio
ETNB
$4K ﹤0.01%
187
GRFS
1180
Grifois
GRFS
$5.27B
$4K ﹤0.01%
398
IBRX icon
1181
ImmunityBio
IBRX
$7.32B
$4K ﹤0.01%
1,610
KROS icon
1182
Keros Therapeutics
KROS
$202M
$4K ﹤0.01%
111
MIRM icon
1183
Mirum Pharmaceuticals
MIRM
$6.96B
$4K ﹤0.01%
148
MNKD icon
1184
MannKind Corp
MNKD
$1.22B
$4K ﹤0.01%
1,058
PKST
1185
DELISTED
Peakstone Realty Trust
PKST
$4K ﹤0.01%
+159
New +$4.13K
PLRX icon
1186
Pliant Therapeutics
PLRX
$66.9M
$4K ﹤0.01%
196
RYTM icon
1187
Rhythm Pharmaceuticals
RYTM
$7.28B
$4K ﹤0.01%
227
SPOT icon
1188
PUT
Spotify
SPOT
$102B
$4K ﹤0.01%
+100
New +$14.5K
TVTX icon
1189
Travere Therapeutics
TVTX
$5.27B
$4K ﹤0.01%
258
TWST icon
1190
Twist Bioscience
TWST
$5.39B
$4K ﹤0.01%
210
DCPH
1191
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$4K ﹤0.01%
272
CBAY
1192
DELISTED
Cymabay Therapeutics
CBAY
$4K ﹤0.01%
341
EQRX
1193
DELISTED
EQRx, Inc. Common Stock
EQRX
$4K ﹤0.01%
1,964
ACRS icon
1194
Aclaris Therapeutics
ACRS
$750M
$3K ﹤0.01%
248
ADMA icon
1195
ADMA Biologics
ADMA
$1.97B
$3K ﹤0.01%
791
ARCT icon
1196
Arcturus Therapeutics
ARCT
$164M
$3K ﹤0.01%
90
-4,019
-98% -$109K
ARDX icon
1197
Ardelyx
ARDX
$1.25B
$3K ﹤0.01%
754
AVXL icon
1198
Anavex Life Sciences
AVXL
$232M
$3K ﹤0.01%
314
BCYC
1199
Bicycle Therapeutics
BCYC
$276M
$3K ﹤0.01%
103
BNS icon
1200
Scotiabank
BNS
$106B
$3K ﹤0.01%
50

Similar funds

Daiwa Securities Group's Q2 2023 Portfolio in Review

As of Q2 2023, Daiwa Securities Group held 1,380 positions worth $15.1B, up 5.2% from $14.4B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q2 2023 filing shows 61 new, 578 increased, 366 reduced and 37 closed positions. Its largest new stake was Applovin: 95,413 shares worth $2.46M. The largest sale was Public Storage, an estimated $213M.

By sector, the portfolio is most concentrated in Real Estate at 54% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q2 2023 buy was Applovin: 95,413 shares worth $2.46M.
  • Daiwa Securities Group added most to Simon Property Group in Q2 2023, an estimated $105M increase.
  • Daiwa Securities Group's biggest Q2 2023 reduction was Public Storage, cutting an estimated $213M.
  • Daiwa Securities Group fully exited BWX Technologies in Q2 2023, selling an estimated $6.7M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $15.1B portfolio in Q2 2023.
  • Daiwa Securities Group opened 61 new positions and closed 37 in Q2 2023.
  • Daiwa Securities Group's portfolio value rose 5.2% quarter-over-quarter to $15.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2023, filed 31 Jul 2023.